Equity Profile

TDOC

Teladoc Health, Inc.

Health CareHealth Care Technology$1.7B

Jul29Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Teladoc Health, Inc. (TDOC) is a leader in health care technology, providing telehealth services that connect patients with medical professionals remotely....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability, and investors will be looking for signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth will indicate how well Teladoc is expanding its customer base and service offerings in a competitive market.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TDOC Q2-2026 Earnings Preview

Context

Company Snapshot

Teladoc Health, Inc. (TDOC) is a leader in health care technology, providing telehealth services that connect patients with medical professionals remotely. As the demand for virtual health care continues to rise, Teladoc plays a crucial role in making healthcare more accessible and convenient.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-163.97%

Avg Stock Reaction

-1.94%

Last Quarter Recap

In Q1 2026, Teladoc reported an EPS of -$0.36, missing expectations by 14%. The stock reacted negatively, dropping 0.83% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Teladoc's upcoming earnings are mixed, with uncertainty around profitability and growth metrics. Investors are keen to see if the company can turn around its recent performance.

Bull Case

If Teladoc can demonstrate a significant increase in telehealth visits and show signs of narrowing losses, it could restore investor confidence and drive the stock higher.

Bear Case

Conversely, if the company continues to report losses and fails to show substantial revenue growth, it may lead to further declines in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported number of telehealth visits this quarter?

This metric is crucial as it directly reflects demand for Teladoc's services and can impact future revenue growth.

How does management plan to address ongoing losses?

Investors will be looking for a clear strategy to improve profitability, which could influence market sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for a rebound in telehealth demand as more consumers become accustomed to virtual care.

Supporting Evidence

Options are pricing in a 32.79% move, indicating expectations of volatility that may not align with historical performance.

The recent trend of increasing telehealth adoption could suggest that Teladoc's growth potential is stronger than analysts predict.

Key Risk

If telehealth visits exceed expectations significantly, it could challenge the current bearish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Teladoc can successfully grow its user base and improve financial performance.

Bull Confirmed If

A significant increase in telehealth visits, exceeding previous quarters, would support a bullish outlook.

Bear Confirmed If

Continued losses without a clear path to profitability would confirm bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±32.79%

Historical Avg

±2.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±32.8% while TDOC has averaged ±2.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

57.5%

Calls (2.4M)P/C Ratio: 0.05Puts (120K)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Mixed flows

Institutional

75.86%

of float

Insider

0.65%

of float

Holders

465

institutions

Top Holders· as of Dec 2025

Vanguard Group Inc
21,483,707 sh · $123.5M
11.91%
-1.9%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teladoc beats expectations, history suggests the stock could rise by an average of 2.54%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting ongoing investor caution.

Miss

Should the company miss expectations, history suggests a potential decline of around 1.82%, indicating continued investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on the number of telehealth visits compared to previous quarters.
2Management's strategy for improving profitability and addressing losses.
3Any new partnerships or expansions in service offerings.
4Insights into customer satisfaction and retention rates.
5Future guidance on revenue expectations for the next quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Teladoc Health, Inc. (TDOC) is a leader in health care technology, providing telehealth services that connect patients with medical professionals remotely....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of profitability, and investors will be looking for signs of improvement or continued losses.

N/A

Revenue Growth

Revenue growth will indicate how well Teladoc is expanding its customer base and service offerings in a competitive market.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

TDOC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

-163.97%

Avg Stock Reaction

-1.94%

Last Quarter Recap

In Q1 2026, Teladoc reported an EPS of -$0.36, missing expectations by 14%. The stock reacted negatively, dropping 0.83% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Teladoc can demonstrate a significant increase in telehealth visits and show signs of narrowing losses, it could restore investor confidence and drive the stock higher.

Bear Case

Conversely, if the company continues to report losses and fails to show substantial revenue growth, it may lead to further declines in the stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the reported number of telehealth visits this quarter?

This metric is crucial as it directly reflects demand for Teladoc's services and can impact future revenue growth.

How does management plan to address ongoing losses?

Investors will be looking for a clear strategy to improve profitability, which could influence market sentiment.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for a rebound in telehealth demand as more consumers become accustomed to virtual care.

Supporting Evidence

Options are pricing in a 32.79% move, indicating expectations of volatility that may not align with historical performance.

The recent trend of increasing telehealth adoption could suggest that Teladoc's growth potential is stronger than analysts predict.

Key Risk

If telehealth visits exceed expectations significantly, it could challenge the current bearish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Teladoc can successfully grow its user base and improve financial performance.

Bull Confirmed If

A significant increase in telehealth visits, exceeding previous quarters, would support a bullish outlook.

Bear Confirmed If

Continued losses without a clear path to profitability would confirm bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±32.79%

Historical Avg

±2.5%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±32.8% while TDOC has averaged ±2.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

57.5%

Calls (2.4M)P/C Ratio: 0.05Puts (120K)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Mixed flows

Institutional

75.86%

of float

Insider

0.65%

of float

Holders

465

institutions

Top Holders· as of Dec 2025

Vanguard Group Inc
21,483,707 sh · $123.5M
11.91%
-1.9%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Teladoc beats expectations, history suggests the stock could rise by an average of 2.54%, confirming a positive turnaround.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted reaction, reflecting ongoing investor caution.

Miss

Should the company miss expectations, history suggests a potential decline of around 1.82%, indicating continued investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on the number of telehealth visits compared to previous quarters.
2Management's strategy for improving profitability and addressing losses.
3Any new partnerships or expansions in service offerings.
4Insights into customer satisfaction and retention rates.
5Future guidance on revenue expectations for the next quarter.